Literature DB >> 19714497

CNS immune responses following experimental stroke.

Dannielle Zierath1, Matthew Thullbery, Jessica Hadwin, J Michael Gee, Anna Savos, Angela Kalil, Kyra J Becker.   

Abstract

BACKGROUND AND
PURPOSE: Animals subjected to an inflammatory insult with lipopolysaccharide (LPS) at the time of stroke are predisposed to develop a detrimental autoimmune response to myelin basic protein (MBP). In this study, we sought to determine whether other inflammatory stimuli could similarly invoke central nervous system (CNS) autoimmunity and whether these detrimental autoimmune responses occurred to antigens other than MBP.
METHODS: Male Lewis rats underwent 3 h middle cerebral artery occlusion (MCAO) and received intraperitoneal injections of LPS, staphylococcal enterotoxin B (SEB), lipoteichoic acid (LTA) or saline at the time of reperfusion. Behavioral tests were performed at set time intervals after MCAO and animals were sacrificed at 1 month to analyze the immune response to MBP, neuron specific enolase (NSE) and proteolipid protein (PLP).
RESULTS: Lymphocytes from SEB treated animals were highly reactive to all tested CNS antigens, but treatment with LPS was most likely to lead to a TH: 1(+) response. A TH: 1(+) response to MBP, NSE or PLP in spleen was associated with worse outcome, although the response to NSE was most predictive of poor outcome. Animals with a cell mediated autoimmune response to either MBP or NSE in spleen had a concomitant humoral response to these antigens.
CONCLUSIONS: These data show that LPS, but not other inflammatory stimuli, increase the likelihood of developing a detrimental autoimmune response to an array of brain antigens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19714497      PMCID: PMC2962560          DOI: 10.1007/s12028-009-9270-4

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  56 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  Superantigen-induced regulatory T cells in vivo.

Authors:  Fredrik Ivars
Journal:  Chem Immunol Allergy       Date:  2007

3.  Fractalkine and vascular injury.

Authors:  H Umehara; E Bloom; T Okazaki; N Domae; T Imai
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

4.  Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice.

Authors:  Can-Xiang Cao; Qing-Wu Yang; Feng-Lin Lv; Jie Cui; Hua-Bin Fu; Jing-Zhou Wang
Journal:  Biochem Biophys Res Commun       Date:  2006-12-18       Impact factor: 3.575

5.  CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.

Authors:  Stefan Kastenbauer; Uwe Koedel; Manfred Wick; Bernd C Kieseier; Hans-Peter Hartung; Hans-Walter Pfister
Journal:  J Neuroimmunol       Date:  2003-04       Impact factor: 3.478

6.  Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I.

Authors:  Paola Zaccone; Zoltán Fehérvári; Lucy Blanchard; Ferdinando Nicoletti; Carl K Edwards; Anne Cooke
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

7.  Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.

Authors:  T Imai; K Hieshima; C Haskell; M Baba; M Nagira; M Nishimura; M Kakizaki; S Takagi; H Nomiyama; T J Schall; O Yoshie
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

8.  Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury.

Authors:  Prabal K Chatterjee; Kai Zacharowski; Salvatore Cuzzocrea; Paul A J Brown; Keith N Stewart; Helder Mota-Filipe; Christoph Thiemermann
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

9.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

10.  Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial.

Authors:  S Aslanyan; C J Weir; H-C Diener; M Kaste; K R Lees
Journal:  Eur J Neurol       Date:  2004-01       Impact factor: 6.089

View more
  24 in total

Review 1.  Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?

Authors:  Catherine E Downes; Peter J Crack
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Modulation of the postischemic immune response to improve stroke outcome.

Authors:  Kyra J Becker
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

3.  Autoimmune responses to brain following stroke.

Authors:  Kyra Becker
Journal:  Transl Stroke Res       Date:  2012-04-05       Impact factor: 6.829

Review 4.  How and why do T cells and their derived cytokines affect the injured and healthy brain?

Authors:  Anthony J Filiano; Sachin P Gadani; Jonathan Kipnis
Journal:  Nat Rev Neurosci       Date:  2017-04-27       Impact factor: 34.870

5.  Activation of immune responses to brain antigens after stroke.

Authors:  Kyra J Becker
Journal:  J Neurochem       Date:  2012-11       Impact factor: 5.372

6.  The contribution of antibiotics, pneumonia and the immune response to stroke outcome.

Authors:  Kyra J Becker; Dannielle Zierath; Allison Kunze; Leia Fecteau; Brian Lee; Shawn Skerrett
Journal:  J Neuroimmunol       Date:  2016-04-16       Impact factor: 3.478

7.  Reduction of the systemic inflammatory induced by acute cerebral infarction through ultra-early thrombolytic therapy.

Authors:  Lichao Ye; Ruowei Cai; Meili Yang; Jiaqiang Qian; Zhilin Hong
Journal:  Exp Ther Med       Date:  2015-08-06       Impact factor: 2.447

8.  Variation in behavioral deficits and patterns of recovery after stroke among different rat strains.

Authors:  Allison Kunze; Dannielle Zierath; Olga Drogomiretskiy; Kyra Becker
Journal:  Transl Stroke Res       Date:  2014-04-08       Impact factor: 6.829

9.  Autoimmune responses to the brain after stroke are associated with worse outcome.

Authors:  Kyra J Becker; Angela J Kalil; Pat Tanzi; Dannielle K Zierath; Anna V Savos; J Michael Gee; Jessica Hadwin; Kelly T Carter; Dean Shibata; Kevin C Cain
Journal:  Stroke       Date:  2011-07-28       Impact factor: 7.914

10.  α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke.

Authors:  Anna V Savos; J Michael Gee; Dannielle Zierath; Kyra J Becker
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-11       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.